Edick Paul R 4
4 · Xeris Biopharma Holdings, Inc. · Filed Dec 14, 2022
Insider Transaction Report
Form 4
Edick Paul R
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2022-12-13$1.45/sh+20,000$29,000→ 1,528,064 total
Holdings
- 33,430(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.